NCT07297771

Brief Summary

This single-visit, laboratory study will quantify latissimus dorsi activation during standardized band/body-weight exercises commonly used in rehabilitation (e.g., standing bent-over row, inferior glide, seated press-up, body-lifting). Healthy, physically active adults (18-40 y; Tegner ≥5) will perform three repetitions per exercise with metronome-paced phases (≈3 s concentric, 3 s isometric, 3 s eccentric), 5-s rest between repetitions and 2-min between exercises; load will be individualized to reach OMNI RPE 6-8. Surface EMG (TeleMyo DTS; Noraxon) will be recorded from the latissimus dorsi (medial and lateral) and selected synergists (teres major, infraspinatus, posterior deltoid, triceps); electrode placement will follow SENIAM recommendations. Signals will be band-pass filtered (20-500 Hz), rectified, RMS-smoothed with a 100-ms window, and normalized to %MVIC using standardized MVC tests; exercise/MVC order will be randomized to limit bias. The primary outcome is mean normalized EMG amplitude per exercise; secondary outcomes include peak amplitude and categorical activation levels (low ≤20% MVIC, moderate 21-40%, high 41-60%, very high \>60%). The study involves minimal risk (possible mild skin irritation under electrodes and transient post-exercise fatigue).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 22, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2026

Completed
Last Updated

December 29, 2025

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

December 9, 2025

Last Update Submit

December 22, 2025

Conditions

Keywords

Latissimus DorsiShoulderElectromyography

Outcome Measures

Primary Outcomes (1)

  • Electromyography

    Surface EMG from the latissimus dorsi (medial and lateral sites) will be recorded with an 8-channel system (TeleMyo DTS; Noraxon). Skin will be shaved and cleaned with 70% isopropyl alcohol; bipolar Ag/AgCl electrodes will be placed per SENIAM with a 2 cm inter-electrode distance (MLD \~lateral to T9; LLD \~4 cm inferior to the scapular inferior angle, midway between the spine and lateral trunk). A synchronized video (Logitech C920) will mark movement onset/offset and will be deleted after analysis (no copies kept). Signals will be normalized to %MVIC using three 5-s MVIC trials (30-s rest between trials; \~2-min between muscles) performed in standardized positions with verbal encouragement. The outcome is the mean %MVIC during the steady phase of each exercise.

    Baseline (Day 1)

Secondary Outcomes (2)

  • Electromyography-Other muscles

    Baseline (Day 1)

  • Activity Level

    Baseline (Day 1)

Study Arms (1)

Healthy adults

Single-visit laboratory cohort. Physically active adults perform exercises; surface EMG is recorded from the latissimus dorsi

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Participants will perform six standardized pulling tasks-inferior glide, low row, seated row, bent-over row, seated press-up, and body lifting-using a resistance band or body weight. Each exercise is done for 3 repetitions with \~5 s between reps and \~2 min between exercises. Resisted exercises follow a metronome-paced 3 s concentric / 3 s isometric / 3 s eccentric tempo; purely isometric tasks are held for 3 s. Load is individualized with the OMNI 0-10 scale and increased during up to 10 familiarization reps until perceived exertion reaches 6-8/10. Exercise order is randomized to minimize ordering effects.

Healthy adults

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy, physically active adults aged 18-40 years. Eligibility requires Tegner ≥5, full glenohumeral range of motion, no shoulder/cervical/lumbar complaints in the past 6 months, and no systemic or neurological disease.

You may qualify if:

  • Age 18-40 years
  • No range-of-motion restriction at the glenohumeral joint
  • No shoulder, cervical, or lumbar region complaints/injury within the past 6 months
  • No systemic or neurological disease
  • Competent to consent and provides written informed consent
  • Tegner Activity Scale ≥ 5

You may not qualify if:

  • Body mass index (BMI) \> 25 kg/m²

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Altındag, 06100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Physiotherapy and Rehabilitation

Study Record Dates

First Submitted

December 9, 2025

First Posted

December 22, 2025

Study Start

October 12, 2025

Primary Completion

February 25, 2026

Study Completion

February 25, 2026

Last Updated

December 29, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

No individual participant data (IPD) will be shared. De-identified aggregate results will be disseminated in publications. The dataset includes physiological signals; synchronized videos are deleted after analysis.

Locations